Placenta
Volume 28, Issue 11 , Pages 1133-1140 , November 2007

Expression of Interleukin-27 by Human Trophoblast Cells

  • A. Coulomb-L'Herminé

      Affiliations

    • Service d'Anatomie Pathologique, Hôpital Antoine Béclère, Clamart, France
    • Present address: Service d'Anatomie Pathologique, Institut Curie, Paris, France.
    • ,
  • F. Larousserie

      Affiliations

    • CNRS UMR 8147, Université Paris V, Institut Fédératif de Recherche Necker, Paris, France
    • Service d'Anatomie Pathologique, Hôpital Cochin, Paris, France
    • ,
  • S. Pflanz

      Affiliations

    • Schering-Plough Biopharma (formerly DNAX), Palo Alto, CA, USA
    • ,
  • E. Bardel

      Affiliations

    • CNRS UMR 8147, Université Paris V, Institut Fédératif de Recherche Necker, Paris, France
    • ,
  • R.A. Kastelein

      Affiliations

    • Schering-Plough Biopharma (formerly DNAX), Palo Alto, CA, USA
    • ,
  • O. Devergne

      Affiliations

    • CNRS UMR 8147, Université Paris V, Institut Fédératif de Recherche Necker, Paris, France
    • Corresponding Author InformationCorresponding author. CNRS UMR 8147, Université Paris V, Institut Fédératif de Recherche Necker, Hôpital Necker, Bâtiment Sèvres, 161 rue de Sèvres, 75015 Paris, France. Tel.: +33 1 44 49 53 87; fax: +33 1 44 49 06 76.

,Accepted 13 June 2007.

References 

  1. Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, Kieff E, et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol. 1996;70:1143–1153
  2. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity. 2002;16:779–790
  3. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, Bazan JF, et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol. 2004;172:2225–2231
  4. Lucas S, Ghilardi N, Li J, de Sauvage FJ. IL-27 regulates IL-12 responsiveness of naive CD4+T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci USA. 2003;100:15047–15052
  5. Morishima N, Owaki T, Asakawa M, Kamiya S, Mizuguchi J, Yoshimoto T. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. J Immunol. 2005;175:1686–1693
  6. Yoshimoto T, Okada K, Morishima N, Kamyia S, Owaki T, Asakawa M, et al. Induction of IgG2a class switching in B cells by IL-27. J Immunol. 2004;173:2479–2485
  7. Larousserie F, Charlot P, Bardel E, Froger J, Kastelein RA, Devergne O. Differential effects of IL-27 on human B cell subsets. J Immunol. 2006;176:5890–5897
  8. Shimizu M, Shimamura M, Owaki T, Asakawa M, Fujita K, Kudo M, et al. Antiangiogenic and antitumor activities of IL-27. J Immunol. 2006;176:7317–7324
  9. Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol. 2005;5:521–531
  10. Golgan J, Rothman P. All in the family: IL-27 suppression of TH-17 cells. Nat Immunol. 2006;7:899–901
  11. Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol. 2007;25:221–242
  12. Larousserie F, Pflanz S, Coulomb-L'Herminé A, Brousse N, Kastelein R, Devergne O. Expression of IL-27 in human Th1-associated granulomatous diseases. J Pathol. 2004;202:164–171
  13. Larousserie F, Bardel E, Pflanz S, Arnulf B, Lome-Maldonado C, Hermine O, et al. Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. Am J Pathol. 2005;166:1217–1228
  14. Larousserie F, Bardel E, Coulomb-L'Herminé A, Canioni D, Brousse N, Kastelein RA, et al. Variable expression of Epstein-Barr virus-induced gene 3 during normal B-cell differentiation and among B-cell lymphomas. J Pathol. 2006;209:360–368
  15. Devergne O, Birkenbach M, Kieff E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA. 1997;94:12041–12046
  16. Devergne O, Coulomb-L'Herminé A, Capel F, Moussa M, Capron F. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol. 2001;159:1763–1776
  17. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol. 2006;6:584–594
  18. Le Bouteiller P, Legrand-Abravanel F, Solier C. Soluble HLA-G1 at the materno-foetal interface. Placenta. 2003;24(Suppl. A):S10–S15
  19. Fons P, Chabot S, Cartwright JE, Lenfant F, L'faqihi F, Giustiniani J, et al. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood. 2006;108:2608–2615
  20. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol. 2003;171:1376–1384
  21. Nagai T, Devergne O, Mueller TF, Perkins DL, Maguire van Seventer J, van Seventer GA. Timing of IFN-β exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-β-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J Immunol. 2003;17:5233–5243
  22. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-foetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol Today. 1993;14:353–356
  23. Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J. Reproductive immunology 2003: reassessing the Th1/Th2 paradigm?. Immunol Lett. 2004;92:207–214
  24. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol. 2006;7:929–936
  25. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol. 2006;7:937–945
  26. Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, Yoshida H, et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity. 2003;19:645–655
  27. Hamano S, Himeno K, Miyazaki Y, Ishii K, Yamanaka A, Takeda A, et al. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity. 2003;19:657–667
  28. Wirtz S, Tubbe I, Galle PR, Schild HJ, Birkenbach M, Blumberg RS, et al. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med. 2006;203:1875–1881
  29. Villarino AV, Larkin J, Saris CJ, Caton AJ, Lucas S, Wong T, et al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol. 2005;174:7684–7691
  30. Boyson JE, Rybalov B, Koopman LA, Exley M, Balk SP, Racke FK, et al. CD1d and invariant NKT cells at the human maternal-fetal interface. Proc Natl Acad Sci USA. 2002;99:13741–13746
  31. Shao L, Jacobs AR, Johnson VV, Mayer L. Activation of CD8+ regulatory T cells by human placental trophoblasts. J Immunol. 2005;174:7539–7547
  32. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod. 2004;10:347–353
  33. Somerset DA, Sheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+CD4+ regulatory T-cell subset. Immunology. 2004;112:38–43
  34. Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de Groot-Swings GM, et al. Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during human pregnancy. Placenta. 2006;27(Suppl. A):S47–S53
  35. Zenclussen AC. Regulatory T cells in pregnancy. Springer Semin Immun. 2006;28:31–39
  36. Zhang JH, He H, Borzychowski AM, Takeda K, Akira S, Croy BA. Analysis of cytokine regulators inducing interferon production by mouse uterine natural killer cells. Biol Reprod. 2003;69:404–411
  37. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002;2:656–663
  38. ParhamNK cells P. trophoblasts: partners in pregnancy. J Exp Med. 2004;200:951–955
  39. Tabiasco J, Rabot M, Aguerre-Girr M, El Costa H, Berrebi A, Parant O, et al. Human decidual NK cells: unique phenotype and functional properties—a review. Placenta. 2006;27(Suppl. A):S34–S39
  40. Le Bouteiller P, Tabiasco J. Killers become builders during pregnancy. Nat Med. 2006;12:991–992
  41. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes at the human fetal–maternal interface. Nat Med. 2006;12:1065–1074
  42. Ashkar AA, Di Santo JP, Croy BA. Interferon γ contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med. 2000;192:259–269
  43. Yamanaka A, Hamano S, Miyazaki Y, Ishii K, Takeda A, Mak TW, et al. Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in concanavalin A-induced hepatitis. J Immunol. 2004;172:3590–3596
  44. Ledée-Bataille N, Dubanchet S, Coulomb-L'Herminé A, Durand-Gasselin I, Frydman R, Chaouat G. A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated inplantation failure after in vitro fertilization. Fertil Steril. 2004;81:59–65
  45. Ashton SV, Whitley GS, Dash PR, Wareing M, Crocker IP, Baker PN, et al. Uterine spiral artery remodeling involves endothelial apoptosis induced by extravillous trophoblasts through Fas/FasL interactions. Arterioscler Thromb Vasc Biol. 2005;25:102–108
  46. Ostojic S, Dubanchet S, Chaouat G, Abdelkarim M, Truyens C, Capron F. Demonstration of the presence of IL-16, IL-17 and IL-18 at the murine fetomaternal interface during murine pregnancy. Am J Reprod Immunol. 2003;49:101–112
  47. Pongcharoen S, Somran J, Sritippayawan S, Niumsup P, Chanchan P, Butkhamchot P, et al. Interleukin-17 expression in the human placenta. Placenta. 2007;28:59–63
  48. Batten M, Ghilardi N. The biology and therapeutic potential of interleukin 27. J Mol Med. 2007;[Epub ahead of print; PubMed ID: 17294231]

PII: S0143-4004(07)00148-8

doi: 10.1016/j.placenta.2007.06.004

Placenta
Volume 28, Issue 11 , Pages 1133-1140 , November 2007

Article Tools

* Image Usage & Resolution